| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |